Myopathy, drug-induced: Difference between revisions
Jump to navigation
Jump to search
Ttenbergen (talk | contribs) mNo edit summary |
|||
| (10 intermediate revisions by 4 users not shown) | |||
| Line 1: | Line 1: | ||
{{ICD10 dx | |||
|ICD10 Code=G72.0 | |||
}} | |||
{{ICD10 category|Neuro}} | |||
{{ICD10 category|Muscle problem}} | |||
{{ICD10 transition status | {{ICD10 transition status | ||
| OldDxArticle =Myopathy| CurrentStatus = | | OldDxArticle =Myopathy| CurrentStatus = reconciled | ||
| InitialEditorAssigned = Joyce Peterson | | InitialEditorAssigned = Joyce Peterson | ||
}} | }} | ||
== Additional Info == | == Additional Info == | ||
incl paralytics, steroids, {sc:alcohol} | incl paralytics, steroids, {sc:alcohol} | ||
*A drug-induced, or toxic, myopathy is defined as the acute or subacute manifestation of myopathic symptoms such as muscle weakness, myalgia, creatine kinase elevation, or myoglobinuria that can occur in patients without muscle disease when they are exposed to certain drugs. | |||
*Toxic myopathies are often a diagnosis of exclusion, as the differential diagnosis for muscle symptoms can be quite broad. Endocrine disorders such as hypothyroidism, hyperthyroidism, and hyperparathyroidism are common causes of elevated CK and muscle weakness and always should be considered when toxic myopathy is suspected. Similarly, muscular dystrophies such as limb girdle muscular dystrophy, dystrophinopathies, Becker’s muscular dystrophy, or Duchenne’s muscular dystrophy can also mimic symptoms of drug-induced myopathies. Metabolic disorders such as glycogen or lipid storage diseases, mitochondrial myopathies, and nutritional deficiencies can cause exercise intolerance, elevated CK, myalgias, or weakness. Inflammatory diseases such as polymyositis, dermatomyositis, or inclusion body myositis also should be considered and excluded through muscle biopsy, as these disorders have different therapeutic implications. | |||
*Steroid myopathy is usually an insidious disease process that causes weakness mainly to the proximal muscles of the upper and lower limbs and to the neck flexors | |||
== Alternate ICD10s to consider coding instead == | {{ICD10 Acquired neuromuscular weakness}} | ||
( | |||
== Alternate ICD10s to consider coding instead or in addition == | |||
*[[Mitochondrial myopathy]] | |||
*[[Paraneoplastic neuropathy or myopathy]] | |||
*[[Myopathy, alcoholic]] | |||
*[[Muscle disorder/myopathy (primary or secondary), NOS]] | |||
{sc:alcohol} | {sc:alcohol} | ||
== Candidate [[Combined ICD10 codes]] == | == Candidate [[Combined ICD10 codes]] == | ||
*[[Myoglobinuria]] | *[[Myoglobinuria]] | ||
== Related CCI Codes == | |||
{{Data Integrity Check List}} | |||
== Related Articles == | == Related Articles == | ||
{{Related Articles}} | {{Related Articles}} | ||
{{ICD10 footer}} | {{ICD10 footer}} | ||
{{EndPlaceHolder}} | {{EndPlaceHolder}} | ||
Latest revision as of 21:10, 2020 August 27
| ICD10 Diagnosis | |
| Dx: | Myopathy, drug-induced |
| ICD10 code: | G72.0 |
| Pre-ICD10 counterpart: | Myopathy |
| Charlson/ALERT Scale: | none |
| APACHE Como Component: | none |
| APACHE Acute Component: | none |
| Start Date: | |
| Stop Date: | |
| External ICD10 Documentation | |
This diagnosis is a part of ICD10 collection.
Additional Info
incl paralytics, steroids, {sc:alcohol}
- A drug-induced, or toxic, myopathy is defined as the acute or subacute manifestation of myopathic symptoms such as muscle weakness, myalgia, creatine kinase elevation, or myoglobinuria that can occur in patients without muscle disease when they are exposed to certain drugs.
- Toxic myopathies are often a diagnosis of exclusion, as the differential diagnosis for muscle symptoms can be quite broad. Endocrine disorders such as hypothyroidism, hyperthyroidism, and hyperparathyroidism are common causes of elevated CK and muscle weakness and always should be considered when toxic myopathy is suspected. Similarly, muscular dystrophies such as limb girdle muscular dystrophy, dystrophinopathies, Becker’s muscular dystrophy, or Duchenne’s muscular dystrophy can also mimic symptoms of drug-induced myopathies. Metabolic disorders such as glycogen or lipid storage diseases, mitochondrial myopathies, and nutritional deficiencies can cause exercise intolerance, elevated CK, myalgias, or weakness. Inflammatory diseases such as polymyositis, dermatomyositis, or inclusion body myositis also should be considered and excluded through muscle biopsy, as these disorders have different therapeutic implications.
- Steroid myopathy is usually an insidious disease process that causes weakness mainly to the proximal muscles of the upper and lower limbs and to the neck flexors
Guidelines for Acquired neuromuscular weakness
- Many acutely ill (especially critically ill) patients develop/acquire weakness while in hospital
- But, there are a variety of different causes of such weakness, including related to problems with nerves (neuropathies) and muscles (myopathies). While there are some ways to distinguish among these (e.g. use of EMG/NCV testing) this is almost never done because other than avoidance, there are no real treatments for any of these, i.e. they're all treated with rehabilitation.
- Here are the specific diagnostic codes we have to cover these various causes:
- Acquired neuropathies:
- Acquired myopathies:
- Muscle, wasting/atrophy NOS -- this INCLUDES weakness/wasting/atrophy due to deconditioning
- Myopathy, drug-induced
- Muscle disorder/myopathy (primary or secondary), NOS
- Muscle, disorder NOS
- When it's not even clear whether the problem is due to muscle or nerves
Alternate ICD10s to consider coding instead or in addition
- Mitochondrial myopathy
- Paraneoplastic neuropathy or myopathy
- Myopathy, alcoholic
- Muscle disorder/myopathy (primary or secondary), NOS
{sc:alcohol}
Candidate Combined ICD10 codes
Related CCI Codes
Data Integrity Checks (automatic list)
none found
Related Articles
Show all ICD10 Subcategories